The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis
- PMID: 33933162
- PMCID: PMC8088720
- DOI: 10.1186/s13756-021-00943-6
The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis
Abstract
Background and aim: Staphylococcus aureus (S. aureus) is one of the most common pathogens causing nosocomial and community-acquired infections with high morbidity and mortality rates. Fusidic acid has been increasingly used for the treatment of infections due to methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). The present study aimed to determine the precise prevalence of fusidic acid resistant MRSA (FRMRSA), fusidic acid resistant MSSA (FRMSSA), and total fusidic acid resistant S. aureus (FRSA) on a global scale.
Methods: Several international databases including Medline, Embase, and the Web of Sciences were searched (2000-2020) to discern studies addressing the prevalence of FRSA, FRMRSA, and FRMSSA. STATA (version14) software was used to interpret the data.
Results: Of the 1446 records identified from the databases, 215 studies fulfilled the eligibility criteria for the detection of FRSA (208 studies), FRMRSA (143 studies), and FRMSSA (71 studies). The analyses manifested that the global prevalence of FRSA, FRMRSA, and FRMSSA was 0.5%, 2.6% and 6.7%, respectively.
Conclusion: This meta-analysis describes an increasing incidence of FRSA, FRMSSA, and FRMRSA. These results indicate the need for prudent prescription of fusidic acid to stop or diminish the incidence of fusidic acid resistance as well as the development of strategies for monitoring the efficacy of fusidic acid use.
Keywords: Fusidic acid; MRSA; Meta-analysis; Staphylococcus aureus.
Conflict of interest statement
AVB is an employee of bioMérieux, a French company developing diagnostic tools for infectious diseases. The company has had no influence on the design and execution of the current study. No competing interests apply for the other authors.
Figures
Similar articles
-
Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.BMC Microbiol. 2015 Oct 13;15:210. doi: 10.1186/s12866-015-0552-z. BMC Microbiol. 2015. PMID: 26463589 Free PMC article.
-
Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.Antimicrob Agents Chemother. 2010 Dec;54(12):4985-91. doi: 10.1128/AAC.00523-10. Epub 2010 Sep 20. Antimicrob Agents Chemother. 2010. PMID: 20855746 Free PMC article.
-
Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.FEMS Immunol Med Microbiol. 2012 Mar;64(2):212-8. doi: 10.1111/j.1574-695X.2011.00887.x. FEMS Immunol Med Microbiol. 2012. PMID: 22066960
-
Mupirocin resistance in Staphylococcus aureus: A systematic review and meta-analysis.J Glob Antimicrob Resist. 2020 Mar;20:238-247. doi: 10.1016/j.jgar.2019.07.032. Epub 2019 Aug 20. J Glob Antimicrob Resist. 2020. PMID: 31442624
-
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.Clin Infect Dis. 2006 Feb 1;42(3):394-400. doi: 10.1086/499365. Epub 2005 Dec 15. Clin Infect Dis. 2006. PMID: 16392088 Review.
Cited by
-
Shea Butter Potentiates the Anti-Bacterial Activity of Fusidic Acid Incorporated into Solid Lipid Nanoparticle.Polymers (Basel). 2022 Jun 16;14(12):2436. doi: 10.3390/polym14122436. Polymers (Basel). 2022. PMID: 35746012 Free PMC article.
-
Analysing the HERV-K env, np9, rec and gag expression in cervical tissues.New Microbes New Infect. 2021 Sep 2;44:100936. doi: 10.1016/j.nmni.2021.100936. eCollection 2021 Nov. New Microbes New Infect. 2021. PMID: 34621524 Free PMC article.
-
The Evaluation of HERV-K np9, rec, gag Expression in Isolated Human Peripheral Blood Mononuclear Cell (PBMC) of Gastric and Colon Cancer.Adv Biomed Res. 2023 May 19;12:131. doi: 10.4103/abr.abr_288_22. eCollection 2023. Adv Biomed Res. 2023. PMID: 37434925 Free PMC article.
-
Antibacterial Activity of Fusidic Acid-Loaded Electrospun Polylactide Fiber Fleeces Against Periodontopathogenic Species.Pharmaceutics. 2025 Jun 24;17(7):821. doi: 10.3390/pharmaceutics17070821. Pharmaceutics. 2025. PMID: 40733030 Free PMC article.
-
Feasibility Study for a Randomised Controlled Trial for the Topical Treatment of Impetigo in Australian General Practice.Trop Med Infect Dis. 2021 Nov 9;6(4):197. doi: 10.3390/tropicalmed6040197. Trop Med Infect Dis. 2021. PMID: 34842831 Free PMC article.
References
-
- Armin S, Fareghi F, Fallah F, Dadashi M, Nikmanesh B, Ghalavand Z. Prevalence of hlg and pvl genes in methicillin resistant Staphylococcus aureus (MRSA) isolated from health care staff in Mofid Children Hospital, Tehran. Iran J Pure Appl Microbiol. 2015;9(2):1001–1005.
-
- Razavi S, Dadashi M, Pormohammad A, Khoramrooz SS, Mirzaii M, Gholipour A, et al. Methicillin-resistant staphylococcus epidermidis in Iran: a systematic review and meta-analysis. Arch Clin Infect Dis. 2018;13(4):e58410.
-
- Foster TJ. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017;41(3):430–449. - PubMed
-
- Dadashi M, Hajikhani B, Darban-Sarokhalil D, van Belkum A, Goudarzi M. Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2020;20:238–247. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical